FDA Inspection 1198281 — Xavier Saez Llorens
The FDA completed an inspection of Xavier Saez Llorens on February 17, 2023 in Tocumen. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- February 17, 2023
- Fiscal Year
- 2023
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Tocumen (Panama)
Additional Details
Clinical Investigator (CI)